CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,303,246 | -35.7% | 566,613 | +2.0% | 0.00% | -100.0% |
| Q2 2023 | $2,026,676 | +4.0% | 555,239 | +1.8% | 0.00% | 0.0% |
| Q1 2023 | $1,947,824 | +149158.5% | 545,624 | +19.2% | 0.00% | – |
| Q4 2022 | $1,305 | -99.9% | 457,667 | +0.8% | 0.00% | – |
| Q3 2022 | $1,013,000 | -39.2% | 454,172 | -32.1% | 0.00% | -100.0% |
| Q2 2022 | $1,666,000 | -54.0% | 668,634 | -9.9% | 0.00% | 0.0% |
| Q1 2022 | $3,620,000 | -62.3% | 741,903 | -12.6% | 0.00% | -66.7% |
| Q4 2021 | $9,606,000 | +257.2% | 849,343 | +360.1% | 0.00% | +200.0% |
| Q3 2021 | $2,689,000 | +186.1% | 184,612 | +128.7% | 0.00% | – |
| Q2 2021 | $940,000 | – | 80,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |